RNN - Rexahn Pharmaceuticals Inc.
Previous close
5.24
5.240 100.000%
Share volume: 0
Last Updated: Fri 07 Jun 2019 10:00:00 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
30%
Profitability
34%
Dept financing
32%
Liquidity
21%
Performance
29%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 2015 - 2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-162.77%
Return on assets
-21.65%
Return on sales
0%
Return on invested capital
192.39%
Total debt ratio
37.87%
Debt ratio change over timeo
-0.54%
Current Ratio
9.03%
Quick Ratio
0%
Cash Position Ratio
3.5%
Short-term ratios 2018 - 2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-40.27%
Return on assets
-28.09%
Return on sales
0%
Return on invested capital
125.6%
Total debt ratio
35.81%
Debt ratio change over timeo
-0.66%
Current Ratio
5.52%
Quick Ratio
0%
Cash Position Ratio
2.02%
Last quarter ratios 2019
The data are presented for the financials results of the last quarter.
Return on equity
-14.7%
Return on assets
-20.22%
Return on sales
0%
Return on invested capital
112.82%
Total debt ratio
17.94%
Debt ratio change over time
-0.83%
Current Ratio
7.57%
Quick Ratio
0%
Cash Position Ratio
2.44%
Performance ratios (change over 4 years) 2015 - 2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-639.41%
Return on assets
-120.1%
Return on sales
0%
Return on invested capital
364.43%
Total debt ratio
-54.28%
Debt ratio change over time
-0.54%
Current Ratio
6.7%
Quick Ratio
0%
Cash Position Ratio
2.37%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RNN | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -162.77% | 1.07% | -8.14% | -11.28% |
| Return on assets | -21.65% | -21.62% | -6.71% | -9.53% |
| Return on sales | 0% | -5539.23% | 0% | -329.56% |
| Return on invested capital | 192.39% | 301.48% | -259.37% | -130.53% |
| Profitability | 41% | 50% | 25% | 0% |
| Total debt ratio | 37.87% | 142.14% | 23.84% | 22.13% |
| Debt ratio change over time | -0.54% | 0.23% | -0.97% | -1.29% |
| Dept financing | 7% | 50% | 4% | 4% |
| Current Ratio | 5.52% | 13.02% | 6.83% | 11.05% |
| Quick Ratio | 0% | 0% | 0% | 10.69% |
| Cash Position Ratio | 2.02% | 12.6% | 2.56% | 2.63% |
| Liquididy | 35% | 44% | 24% | 60% |
| Short-term ratios | RNN | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -40.27% | -33.15% | -14.36% | -5.02% |
| Return on assets | -28.09% | -15.13% | -9.55% | -6.38% |
| Return on sales | 0% | -13599.98% | 0% | -333.95% |
| Return on invested capital | 125.6% | 571.73% | -381.13% | 16.96% |
| Profitability | 30% | 25% | 0% | 51% |
| Total debt ratio | 35.81% | 48.84% | 23.99% | 33.94% |
| Debt ratio change over time | -0.66% | -0.68% | -1.37% | -1.49% |
| Dept financing | 43% | 25% | 12% | 17% |
| Current Ratio | 5.52% | 13.02% | 6.83% | 11.05% |
| Quick Ratio | 0% | 0% | 0% | 10.69% |
| Cash Position Ratio | 2.02% | 12.6% | 2.56% | 2.63% |
| Liquididy | 15% | 50% | 18% | 51% |